NCT07007143View on ClinicalTrials.gov

STrategies for AntithRombotic Treatment Following Transcatheter Edge-to-Edge Repair in Patients Without an Indication for Oral Anticoagulant

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

1,032

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

September 30, 2028

Study Completion Date

September 30, 2029

Conditions
Mitral Regurgitation
Interventions
DRUG

Experimental: Aspirin monotherapy

Aspirin monotherapy

DRUG

Active Comparator: Aspirin+Clopidogrel

Aspirin+Clopidogrel

Trial Locations (1)

100037

Chinese Academy of Medical Sciences, Fuwai Hospital, Beijing

All Listed Sponsors
lead

Chinese Academy of Medical Sciences, Fuwai Hospital

OTHER